CASP10 and melanoma: Inhibition of either caspase-8 or caspase-10 (as well as caspase-8 knockdown) significantly reduces treatment efficacy suggesting that this downstream pathway may play an important role in the response of melanoma cells to the combination treatment (Figure 6).